Format

Send to

Choose Destination
See comment in PubMed Commons below
Gastroenterology. 2001 Feb;120(3):718-25.

Hemochromatosis: diagnosis and management.

Author information

  • 1Division of Gastroenterology and Hepatology, Saint Louis University School of Medicine, St. Louis, Missouri 63110-0250, USA. baconbr@slu.edu

Abstract

HH should be distinguished from the other syndromes of iron overload. Many patients with HH have abnormal serum iron values before the development of any significant symptoms or clinical findings, and liver biopsy is less important in these patients. HFE mutation analysis has strengthened our ability to diagnose HH accurately and is useful in family studies. HFE mutations may play a contributory role in some patients with PCT, NASH, or chronic HCV. Generalized population screening for HH may someday become a reality and lead to the identification and treatment of more patients before they have tissue damage or increased morbidity. With the identification of the HFE gene, we are beginning to unravel many of the mysteries of both normal iron absorption and the disorder of iron metabolism found in patients with HH.

PMID:
11179246
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk